Skip to main content
TipRanks
Go Ultimate75% OFF

Edward Blechschmidt Insider Profile

4 Followers

Edward Blechschmidt, Director at Encompass Health, holds 82.50K shares in Lionbridge Technologies (Ticker: LIOX), holds ― shares in VWR Corp (Ticker: VWR), holds 9.13K shares in Diamond Foods (Ticker: DMND).

Edward Blechschmidt's Trading History

VWR
VWR Corp
Mar 02, 2017―Uninformative Buy――
LIOX
Lionbridge Technologies
Mar 02, 2017―Uninformative Sell474.38K$474.38K
DMND
Diamond Foods
Mar 02, 2016―Uninformative Sell―$343.00K
EHC
Encompass Health
Apr 11, 2012DirectorUninformative Buy1.90K$7.45M
GTIV
Gentiva Health Services
――――
~CBRX
Columbia Laboratories
――――

You May Also Like

Edward Blechschmidt insider profile FAQ

What is the percentage of profitable transactions made by Edward Blechschmidt?
The percentage of profitable transactions made by Edward Blechschmidt is 50%.
What is the average return per transaction made by Edward Blechschmidt?
The average return per transaction made by Edward Blechschmidt is -1.10%.
What stocks does Edward Blechschmidt hold?
Edward Blechschmidt holds: EHC, LIOX, DMND, ~CBRX, GTIV, VWR stocks.
What was Edward Blechschmidt’s latest transaction?
Edward Blechschmidt’s latest transaction was an Uninformative Sell of $474.38K.
What was Edward Blechschmidt's most profitable transaction?
Edward Blechschmidt’s most profitable transaction was an Informative Sell of LIOX stock on March 10, 2014. The return on the trade was 26.50%.
What is Edward Blechschmidt's role in Encompass Health?
Edward Blechschmidt's role in Encompass Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.